These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31425356)

  • 1. Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
    Zhang J; Guo M; Huang ZX; Bao R; Yu Q; Dai M; Wang X; Rao Y
    Chin Med J (Engl); 2019 Sep; 132(17):2089-2095. PubMed ID: 31425356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
    Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
    Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.
    Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z
    Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
    Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y
    J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Systemic Exposure of Pyrazinoic Acid Has Limited Antituberculosis Activity in Murine and Rabbit Models of Tuberculosis.
    Lanoix JP; Tasneen R; O'Brien P; Sarathy J; Safi H; Pinn M; Alland D; Dartois V; Nuermberger E
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4197-205. PubMed ID: 27139472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.
    Manca C; Koo MS; Peixoto B; Fallows D; Kaplan G; Subbian S
    PLoS One; 2013; 8(8):e74082. PubMed ID: 24015316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25(OH)2-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages.
    Crowle AJ; Salfinger M; May MH
    Am Rev Respir Dis; 1989 Feb; 139(2):549-52. PubMed ID: 2492412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
    BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.
    Budzik JM; Jarlsberg LG; Higashi J; Grinsdale J; Hopewell PC; Kato-Maeda M; Nahid P
    PLoS One; 2014; 9(4):e95645. PubMed ID: 24759760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis.
    Ibrahim M; Andries K; Lounis N; Chauffour A; Truffot-Pernot C; Jarlier V; Veziris N
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1011-5. PubMed ID: 17178794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
    Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
    J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.
    Young EF; Perkowski E; Malik S; Hayden JD; Durham PG; Zhong L; Welch JT; Braunstein MS; Hickey AJ
    Pharm Res; 2016 Oct; 33(10):2495-505. PubMed ID: 27351427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
    Grosset J; Truffot-Pernot C; Lacroix C; Ji B
    Antimicrob Agents Chemother; 1992 Mar; 36(3):548-51. PubMed ID: 1622164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration.
    Lounis N; Veziris N; Chauffour A; Truffot-Pernot C; Andries K; Jarlier V
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3543-7. PubMed ID: 16954317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide.
    Krug S; Gupta M; Kumar P; Feller L; Ihms EA; Kang BG; Srikrishna G; Dawson TM; Dawson VL; Bishai WR
    Nat Commun; 2023 Dec; 14(1):8161. PubMed ID: 38071218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
    Lecoeur HF; Truffot-Pernot C; Grosset JH
    Am Rev Respir Dis; 1989 Nov; 140(5):1189-93. PubMed ID: 2817579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
    Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
    Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.